Healthcare Publications RSV Diagnostics Market

Market Research Future has added a report titled “RSV Diagnostics Market Research Report – Forecast to 2023” to its offering. Market Highlights: Respiratory Syncytial Virus (RSV) is a virus that can cause serious respiratory infections such as pneumonia and bronchitis. The increasing incidence rate of respiratory infections, growing demand for in-vitro diagnostics, and growing neonatal population are major factors propelling the growth of the market. For instance, according to the Centres for Disease Control and Prevention, in the United States, RSV on an average lead to 57,527 hospitalizations among children below five years of age. On the other hand, some factor such as lack of availability of specific treatment options for RSV infections and the high number of other pathogens that cause similar symptoms of respiratory illness may hamper the growth of the market during the assessment period. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6217 Global RSV Diagnostics Key Players: Some of the key players in the global RSV diagnostics market are Quest Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Bio-Rad Laboratories Inc., Alere, Inc., Quidel Corporation, and others. Segmentation: The global RSV diagnostics market is segmented on the basis of the product, method, and end-user. On the basis of the product, the market is classified into kits and assays, instruments, and other products. The global RSV diagnostics market on the basis of the method is segmented into molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. The rapid antigen detection tests are further classified into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. Further, the other rapid antigen detection tests are classified into chromatographic immunoassays and optical immunoassays. Furthermore, on the basis of end-user, the market is segmented into hospitals and clinics, clinical laboratories, home care, and others. Regional Analysis: The Americas is likely to dominate the global RSV diagnostics market during the forecast period. The market growth is attributed to increasing incidences of RSV infections, increasing government funding's, and increasing infant population. Additionally, growing demand for molecular diagnostics and chromatographic immunoassays in this region owing to the high accuracy, sensitivity, and specificity these devices provide. For instance, as per the data stated by the Centres for Disease Control and Prevention, in the United States, RSV leads to an estimated 2.1 million outpatient visits among children below five years of age every year. Europe is anticipated to be the second largest market in the global RSV diagnostics market. The European market is expected to grow during the forecast period owing to the growing occurrence of RSV infections and growing government funding for respiratory diseases. Asia Pacific is expected to be the fastest growing market owing to the high population base, increasing prevalence of respiratory diseases such as pneumonia and bronchitis, and growing demand for automated healthcare testing for the accurate diagnosis of diseases. Furthermore, the Middle East and Africa are expected to show the least growth in the global RSV diagnostics market. The market growth in these regions is attributed to the constantly improving healthcare infrastructure, economic development, and rising patient awareness levels. Browse Full Reports @ https://www.marketresearchfuture.com/reports/rsv-diagnostics- market-6217 Table of Contents: Chapter 1. Report Prologue Chapter 2. Market Introduction Chapter 3. Research Methodology